Thor Grundtvig Theander

PersonUnit number: 4004066540
Greve
2
Ownership
5
Board positions
3
Director positions
2
Other roles
43
People in network

People in network(43)

People who held roles at the same companies, or who co-own the same companies

Ali El-Salanti
ONCOMAL ApS, ONCOMAL ApS, ONCOMAL ApS, VAR2 PHARMACEUTICALS ApS, VAR2 PHARMACEUTICALS ApS, VarCT Diagnostics ApS, VarCT Diagnostics ApS
Mads Daugaard
ONCOMAL ApS, ONCOMAL ApS, ONCOMAL ApS, VAR2 PHARMACEUTICALS ApS, VAR2 PHARMACEUTICALS ApS, VarCT Diagnostics ApS, VarCT Diagnostics ApS
Mai-Britt Zocca
VAR2 PHARMACEUTICALS ApS, ONCOMAL ApS

Ownership(2)

ONCOMAL ApS
CVR: 34580367
EJERREGISTER
10-14,99%
Ownership
Active
FEVACIL ApS
CVR: 30065964
EJERREGISTER
100%
Ownership
Active

Board positions(3)

ONCOMAL ApS
CVR: 34580367
BESTYRELSESMEDLEM
Active
Since 14. maj 2016
VAR2 PHARMACEUTICALS ApS
CVR: 34621942
BESTYRELSESMEDLEM
Active
Since 14. maj 2016
VarCT Diagnostics ApS
CVR: 38733567
BESTYRELSESMEDLEM
Active
Since 1. apr. 2022

Director positions(2)

ONCOMAL ApS
CVR: 34580367
DIREKTØR
Active
Since 9. maj 2012
FEVACIL ApS
CVR: 30065964
DIREKTØR
Active
Since 30. jan. 2014

Other roles(1)

ONCOMAL ApS
CVR: 34580367
STIFTERE
Active
Since 9. maj 2012

Indirect ownership(4)

Companies owned indirectly through ownership chains.

10-14,99%
Effective ownership
Depth: 1
Ownership path:
5-9,99%
Effective ownership
Depth: 1
Ownership path:
ONCOMAL ApS(10-14,99%)
5-9,99%
Effective ownership
Depth: 2
Ownership path:
ONCOMAL ApS(10-14,99%)
VarCT Diagnostics ApS(66,66-89,99%)
AdaptVac ApS
CVR: 38732730
5-9,99%
Effective ownership
Depth: 2
Ownership path:
AdaptVac ApS(50-66,65%)

Former board positions(2)

ACIL ApS
CVR: 25332539
BESTYRELSE
Ended
Since 12. apr. 2000
Until 15. nov. 2006
FEVACIL ApS
CVR: 30065964
BESTYRELSESMEDLEM
Ended
Since 15. nov. 2006
Until 31. dec. 2013

Former director positions(1)

VAR2 PHARMACEUTICALS ApS
CVR: 34621942
DIREKTØR
Ended
Since 1. jun. 2012
Until 18. jan. 2018

Former roles(1)

ACIL ApS
CVR: 25332539
STIFTERE
Ended
Since 12. apr. 2000
Until 15. nov. 2006